Literature DB >> 16341991

Neuroimaging advances and the transformation of acute stroke care.

Doojin Kim1, David S Liebeskind.   

Abstract

Neuroimaging techniques have transformed the delivery of stroke care. Multimodal computed tomography and magnetic resonance imaging rapidly illustrate the vascular and parenchymal correlates in acute ischemic and hemorrhagic stroke. Optimal selection of thrombolytic candidates and the characterization of ischemic sequelae may be achieved with imaging. The nature and topography of intracerebral hemorrhage may also be defined. Increasing use of multimodal imaging in acute stroke has expanded our current understanding of stroke pathophysiology and streamlined the care of stroke patients from the hyperacute to chronic phases. The integration of neuroimaging techniques in research studies has elucidated pitfalls in the translation of novel therapy into clinical practice. This review explores the impact of neuroimaging advances in stroke and emphasizes the critical role of these modalities in the care of patients with ischemic and hemorrhagic events.

Entities:  

Mesh:

Year:  2005        PMID: 16341991     DOI: 10.1055/s-2005-923529

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  3 in total

1.  MR image features predicting hemorrhagic transformation in acute cerebral infarction: a multimodal study.

Authors:  Chunming Liu; Zhengchao Dong; Liang Xu; Aiman Khursheed; Longchun Dong; Zhenxing Liu; Jun Yang; Jun Liu
Journal:  Neuroradiology       Date:  2015-08-18       Impact factor: 2.804

2.  Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling.

Authors:  T L Barr; Y Conley; J Ding; A Dillman; S Warach; A Singleton; M Matarin
Journal:  Neurology       Date:  2010-09-14       Impact factor: 9.910

Review 3.  How well do blood flow imaging and collaterals on angiography predict brain at risk?

Authors:  David S Liebeskind; Nerses Sanossian
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.